Showing results (91-100 of 1,365) with videos related to

Sort By:
Pageof 137
Alzheimer'S & Dementia (Amsterdam, Netherlands)|August 5, 2016
White matter hyperintensities are more highly associated with preclinical Alzheimer's disease than imaging and cognitive markers of neurodegenerationBenjamin M Kandel, Brian B Avants, James C Gee, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|July 26, 2016
Plasma clusterin levels and risk of dementia, Alzheimer's disease, and strokeGalit Weinstein, Alexa S Beiser, Sarah R Preis, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|August 22, 2022
Phenotype-informed polygenic risk scores are associated with worse outcome in individuals at risk of Alzheimer's diseaseKaja Nordengen, Lene Pålhaugen, Francesco Bettella, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 12, 2021
Detection of retinal and blood Aβ oligomers with nanobodiesUmma Habiba, Joseph Descallar, Fabian Kreilaus, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 10, 2021
Comparing CSF amyloid-beta biomarker ratios for two automated immunoassays, Elecsys and Lumipulse, with amyloid PET statusEline A J Willemse, Betty M Tijms, Bart N M van Berckel, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 10, 2021
Spastic paraplegia preceding PSEN1-related familial Alzheimer's diseaseViorica Chelban, Marianthi Breza, Maria Szaruga, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 24, 2021
Transfer learning-trained convolutional neural networks identify novel MRI biomarkers of Alzheimer's disease progressionYi Li, Annat Haber, Christoph Preuss, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|August 2, 2021
ErratumYoung-Gun Lee, Seun Jeon, Sung Woo Kang, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 19, 2020
The influence of diversity on the measurement of functional impairment: An international validation of the Amsterdam IADL Questionnaire in eight countriesMark A Dubbelman, Merike Verrijp, David Facal, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 22, 2020
Amyloid accumulation in Down syndrome measured with amyloid loadMatthew D Zammit, Charles M Laymon, Tobey J Betthauser, et al.
Pageof 137